Invention Grant
- Patent Title: Estimating and correcting for contrast agent extravasation in tissue perfusion imaging
- Patent Title (中): 组织灌注成像中造影剂外渗的估计和矫正
-
Application No.: US13088972Application Date: 2011-04-18
-
Publication No.: US08718747B2Publication Date: 2014-05-06
- Inventor: Atle Bjørnerud , Kyrre Eeg Emblem
- Applicant: Atle Bjørnerud , Kyrre Eeg Emblem
- Applicant Address: NO Oslo
- Assignee: Oslo Universitetssykehus HF
- Current Assignee: Oslo Universitetssykehus HF
- Current Assignee Address: NO Oslo
- Agency: Knobbe Martens Olson & Bear LLP
- Main IPC: A61B6/00
- IPC: A61B6/00

Abstract:
The invention provides a method, an image analysis software product, and a system for medical imaging analysis for estimating contrast agent extravasation in contrast agent based perfusion imaging such as MRI dynamic contrast enhanced (DCE) imaging, and in particular correction, compensation, or visualization of extravascular leakage of contrast agent in tumors. According to the invention, the effect of extravasation is directly manifested in the tail part of an observed, apparent residue function, R′(t), obtained directly by de-convoluting the expression C(t)=R′(t)Cp′(t) with the arterial input function (AIF). A leakage rate or extravasation constant is determined directly from the tail part of the determined apparent residue function. The invention also relates to distinguishing between T1-dominant and T2*-dominant extravasation effects in perfusion imaging to from the sign of the tail part of the determined apparent residue function and to an automated method for DSC-MRI involving correction for contrast agent extravasation and partial volume effects.
Public/Granted literature
- US20110257519A1 ESTIMATING AND CORRECTING FOR CONTRAST AGENT EXTRAVASATION IN TISSUE PERFUSION IMAGING Public/Granted day:2011-10-20
Information query